Bibliometric study of intense pulsed light (IPL) for dry eye disease (DED) and meibomian gland dysfunction (MGD) to characterize current worldwide patterns and offer visual representations of previous and emerging trends.
Background:
DED is a prevalent eye condition and IPL has been reported to be an effective therapy for dry eyes.
Method:
This cross-sectional study examined IPL for DED research evolution and theme trends from 2015 to 2024, using bibliometric analysis of WoSCC data. We examined 4334 IPL articles for publication year, journals, authors, institutions, countries/regions, references, and keywords.
Results:
We found 111 articles from 2015 to 2024 articles and the annual publication rate was less than 10 from 2015 to 2017, but has steadily increased after 2018. Global publication volumes have increased by 1300% in the past decade, from 2 in 2015 to 28 in 2022. Currently, the number of articles stands at 10 in 2024. IPL for DED was published in 43 journals. Currently, the top journals publishing on this topic according to volume include Photobiomodulation, Photomedicine, and Laser Surgery, Journal of Clinical Medicine, and Cornea.
Conclusions:
The number of publications and citations on research related to IPL for DED treatment has steadily increased across numerous countries, institutions, and authors over the past decade. The current study illuminates the current trends, global collaboration patterns, fundamental knowledge, research hotspots, and emerging frontiers of IPL treatment. The primary focus now has been the development of innovative solutions for the treatment of DED and MGD by combining IPL with presenting DED treatment regime.
Get full access to this article
View all access options for this article.
References
1.
StapletonF, AlvesM, BunyaVY, et al.TFOS DEWS II epidemiology report. Ocul Surf, 2017; 15(3):334–365.
2.
CraigJP, NicholsKK, AkpekEK, et al.TFOS DEWS II definition and classification report. Ocul Surf, 2017; 15(3):276–283.
FraunfelderFT, SciubbaJJ, MathersWD. The role of medications in causing dry eye. J Ophthalmol, 2012; 2012:285851–285858.
5.
I.y. HasanZA. Dry eye syndrome risk factors. Saudi Journal of Ophthalmology, 2021; 35(2):131–139.
6.
QianL, WeiW. Identified risk factors for dry eye syndrome: A systematic review and meta-analysis. PLoS One, 2022; 17(8):e0271267.
7.
KamKW, Di ZazzoA, De GregorioC, NarangP, JhanjiV, BasuS. A review on drug-induced dry eye disease. Indian J Ophthalmol, 2023; 71(4):1263–1269.
8.
PflugfelderSC, De PaivaCS. The pathophysiology of dry eye disease. Ophthalmology, 2017; 124(11S):S4–S13.
9.
JonesL, DownieLE, KorbD, et al.TFOS DEWS II management and therapy report. Ocul Surf, 2017; 15(3):575–628.
10.
KorbDR, BlackieCA. Meibomian gland diagnostic expressibility: Correlation with dry eye symptoms and gland location. Cornea, 2008; 27(10):1142–1147.
11.
WangMTM, FengJ, WongJ, TurnbullPR, CraigJP. Randomised trial of the clinical utility of an eyelid massage device for the management of Meibomian gland dysfunction. Cont Lens Anterior Eye, 2019; 42(6):620–624.
12.
LaneSS, DubinerHB, EpsteinRJ, et al.A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea, 2012; 31(4):396–404.
13.
ChenJ, YuS, QinG, et al.Immediate sequential changes in the tear film lipid layer following eyelid massage in dry eye syndrome: A comparative control study. Heliyon, 2024; 10(17):e36590.
14.
LiuR, RongB, TuP, et al.Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating Meibomian gland dysfunction. Am J Ophthalmol, 2017; 183:81–90.
15.
GoldbergDJ. Current trends in intense pulsed light. J Clin Aesthet Dermatol, 2012; 5:45–53.
16.
ToyosR, McGillW, BriscoeD. Intense pulsed light treatment for dry eye disease due to Meibomian gland dysfunction: A 3-Year Retrospective Study. Photomed Laser Surg, 2015; 33(1):41–46.
17.
SongY, YuS, HeX, et al.Tear film interferometry assessment after intense pulsed light in dry eye disease: A randomized, single masked, sham-controlled study. Cont Lens Anterior Eye, 2022; 45(4):101499.
18.
QinG, ChenJ, LiL, et al.Managing severe evaporative dry eye with intense pulsed light therapy. Ophthalmol Ther, 2023; 12(2):1059–1071.
19.
DemolinL, Es-SafiM, SoyfooMS, MotulskyE. Intense pulsed light therapy in the treatment of dry eye diseases: A systematic review and meta-analysis. J Clin Med, 2023; 12(8):3039.
20.
JengSF, ChenJA, ChangLR, et al.Beneficial effect of intense pulsed light on the wound healing in diabetic rats. Lasers Surg Med, 2020; 52(6):530–536.
21.
FanX, XingYZ, LiuLH, et al.Effects of 420‐nm intense pulsed light in an acne animal model. J Eur Acad Dermatol Venereol, 2013; 27(9):1168–1171.
22.
BäumlerW, VuralE, LandthalerM, MuzziF, ShafirsteinG. The effects of intense pulsed light (IPL) on blood vessels investigated by mathematical modeling. Lasers Surg Med, 2007; 39(2):132–139.
23.
JiangP, LiuY, ZhangJ, et al.Mast cell stabilization: New mechanism underlying the therapeutic effect of intense pulsed light on rosacea. Inflamm Res, 2023; 72(1):75–88.
24.
ChienT-W, WangH-Y, KanW-C, SuS-B. Whether article types of a scholarly journal are different in cited metrics using cluster analysis of MeSH terms to display. Medicine (Baltimore), 2019; 98(43):e17631.
25.
SchargusM, KromerR, DruchkivV, FringsA. The top 100 papers in dry eye – A bibliometric analysis. Ocul Surf, 2018; 16(1):180–190.
26.
ChanMW, EppichWJ. The keyword effect: A grounded theory study exploring the role of keywords in clinical communication. AEM Educ Train, 2020; 4(4):403–410.
27.
LogulloP, De BeyerJA, KirtleyS, SchlüsselMM, CollinsGS. Open access journal publication in health and medical research and open science: Benefits, challenges and limitations. BMJ Evid Based Med, 2024; 29(4):223–228.
28.
KoelblingerD, ZimmermannG, WeineckSB, KiesslichT. Size matters! Association between journal size and longitudinal variability of the Journal Impact Factor. PLoS One, 2019; 14(11):e0225360.
29.
QinG, ChenJ, LiL, et al.Efficacy of intense pulsed light therapy on signs and symptoms of dry eye disease: A meta-analysis and systematic review. Indian J Ophthalmol, 2023; 71(4):1316–1325.
30.
LazregS, HosnyM, AhadM, et al.Dry eye disease in the middle east and northern Africa: A position paper on the current state and unmet needs. Clin Ophthalmol, 2024; 18:679–698.
31.
YangW, LuoY, WuS, et al.Estimated annual economic burden of dry eye disease based on a multi-center analysis in China: A Retrospective Study. Front Med (Lausanne), 2021; 8:771352.
32.
PacC-P, Sánchez-GonzálezJ-M, Rocha-De-LossadaC, et al.Intense pulsed light therapy for dry eye disease: Analyzing temporal changes in tear film stability and ocular surface between IPL sessions. Healthcare, 2024; 12(11):1119.
33.
LeiY, PengJ, LiuJ, ZhongJ. Intense pulsed light (IPL) therapy for meibomian gland dysfunction (MGD)–related dry eye disease (DED): A systematic review and meta-analysis. Lasers Med Sci, 2022; 38(1):1.
34.
YuH, ZengW, ZhaoG, HongJ, FengY. Response of tear cytokines following intense pulsed light combined with meibomian gland expression for treating meibomian gland dysfunction-related dry eye. Front Endocrinol (Lausanne), 2022; 13:973962.
35.
Perez-SilgueroMA, Perez-SilgueroD, Rivero-SantanaA, Bernal-BlascoMI, Encinas-PisaP. Combined intense pulsed light and low-level light therapy for the treatment of dry eye: A retrospective before–after study with one-year follow-up. Opth, 2021; 15:2133–2140.
36.
RenX, ChouY, WangY, ChenY, LiuZ, LiX. Comparison of intense pulsed light and near‐infrared light in the treatment of dry eye disease: A prospective randomized study. Acta Ophthalmol, 2021; 99(8):e1307–e1314.
37.
LiQ, LiuJ, LiuC, et al.Effects of intense pulsed light treatment on tear cytokines and clinical outcomes in Meibomian gland dysfunction. PLoS One, 2021; 16(8):e0256533.
38.
D’SouzaS, Padmanabhan NairA, IyappanG, et al.Clinical and molecular outcomes after combined intense pulsed light therapy with low-level light therapy in recalcitrant evaporative dry eye disease with Meibomian gland dysfunction. Cornea, 2022; 41(9):1080–1087.
39.
LiH, HuangL, FangX, et al.The photothermal effect of intense pulsed light and LipiFlow in eyelid related ocular surface diseases: Meibomian gland dysfunction, Demodex and blepharitis. Heliyon, 2024; 10(13):e33852.
40.
ChoiM, HanSJ, JiYW, et al.Meibum expressibility improvement as a therapeutic target of intense pulsed light treatment in meibomian gland dysfunction and its association with tear inflammatory cytokines. Sci Rep, 2019; 9(1):7648.
41.
PacC-P, MunteanuM, Sánchez-GonzálezJ-M, et al.Long-term impacts of intense pulsed light therapy on ocular surface health and tear film dynamics in patients with dry eye disease: Detailed analysis and observations over a 1-year follow-up period. Ophthalmol Ther, 2024; 13(10):2715–2730.
42.
ToyosR, DesaiNR, ToyosM, DellSJ. Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study. PLoS One, 2022; 17(6):e0270268.
43.
MossSE, KleinR, KleinBE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol, 2000; 118(9):1264–1268.
44.
WuY, XuL, SongY, et al.Management of post-LASIK dry eye with intense pulsed light in combination with 0.1% sodium hyaluronate and heated eye mask. Ophthalmol Ther, 2022; 11(1):161–176.
45.
ChenJ, QinG, LiL, et al.The combined impact of intense pulsed light combined and 3% Diquafosol ophthalmic solution on evaporative dry eye: A Randomized Control Study. Ophthalmol Ther, 2023; 12(6):2959–2971.
46.
Gedar TotukÖM, KabadayıK, ÖzkapıC, AykanÜ. Efficacy of intense pulsed light treatment for moderate to severe acute blepharitis or Blepharoconjunctivitis: A retrospective case series. Turk J Ophthalmol, 2021; 51(2):89–94.
47.
GaoY-F, LiuR-J, LiY-X, et al.Comparison of anti-inflammatory effects of intense pulsed light with tobramycin/dexamethasone plus warm compress on dry eye associated meibomian gland dysfunction. Int J Ophthalmol, 2019; 12(11):1708–1713.
48.
WeiS, RenX, WangY, ChouY, LiX. Therapeutic Effect of Intense Pulsed Light (IPL) Combined with Meibomian Gland Expression (MGX) on Meibomian Gland Dysfunction (MGD). J Ophthalmol, 2020; 2020:3684963–3684967.
49.
ChengS-N, JiangF-G, ChenH, GaoH, HuangY-K. Intense pulsed light therapy for patients with meibomian gland dysfunction and ocular demodex infestation. Curr Med Sci, 2019; 39(5):800–809.
50.
LinF, MaoX, MaL, LiuH. An investigation into the effects of ocular nebulization combined with meibomian gland massage on ocular surface status and corneal higher‐order aberrations for the treatment of meibomian gland dysfunction. Acta Ophthalmol, 2022; 100(3):e681–e693.
51.
YangL, PazoEE, QinG, et al.Effect of intense pulsed light on anterior corneal aberrations and quality of vision in patients with evaporative dry eye. Photobiomodul Photomed Laser Surg, 2021; 39(3):185–195.
52.
FanQ, PazoEE, YouY, et al.Subjective quality of vision in evaporative dry eye patients after intense pulsed light. Photobiomodul Photomed Laser Surg, 2020; 38(7):444–451.
53.
WhangW-J, YunJ, KohK. Intense pulsed-light treatment improves objective optical quality in patients with meibomian gland dysfunction. BMC Ophthalmol, 2023; 23(1):191.
54.
ZhangH, QiY, ChenJ, et al.Management of glaucoma-related dry eye disease with intense pulsed light: A randomized control study. Clin Ophthalmol, 2024; 18:2061–2072.
55.
Martinez-De-La-CasaJM, Oribio-QuintoC, Milans-Del-BoschA, et al.Intense pulsed light-based treatment for the improvement of symptoms in glaucoma patients treated with hypotensive eye drops. Eye and Vis, 2022; 9(1).
56.
WangH, YinX, LiY, et al.Safety and efficacy of intense pulsed light in the treatment of severe chronic ocular graft-versus-host disease. Ocul Surf, 2023; 30:276–285.
57.
JiangJ, YangX, DuF, ZhengW, YangY. Therapeutic effect of intense pulsed light on different types of Chalazion in children. Sci Rep, 2024; 14(1):3645.
58.
ZhuY, HuangX, LinL, et al.Efficacy of intense pulsed light in the treatment of recurrent Chalaziosis. Front Med (Lausanne), 2022; 9:839908.
59.
ZhuY, ZhaoH, HuangX, et al.Novel treatment of chalazion using light-guided-tip intense pulsed light. Sci Rep, 2023; 13(1):12393.
60.
AritaR, FukuokaS. Therapeutic efficacy and safety of intense pulsed light for refractive multiple recurrent Chalazia. J Clin Med, 2022; 11(18):5338.
61.
DengX, WuC, LiuM, et al.Effect of comprehensive nursing on patients with chalazion undergoing intense pulsed light and its influence on postoperative recurrence. Am J Transl Res, 2023; 15(9):5691–5698.
62.
LiJ, LiD, ZhouN, QiM, LuoY, WangY. Effects of chalazion and its treatments on the meibomian glands: A nonrandomized, prospective observation clinical study. BMC Ophthalmol, 2020; 20(1):278.
63.
VatanseverF, HamblinMR. Far infrared radiation (FIR): Its biological effects and medical applications. Photonics Lasers in Medicine, 2012; 1.
64.
AndersJJ, MogesH, WuX, et al.In vitro and in vivo optimization of infrared laser treatment for injured peripheral nerves. Lasers Surg Med, 2014; 46(1):34–45.
65.
HamblinMR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys, 2017; 4(3):337–361.
ChengY, SongWJ, HuangMT, et al.Efficacy of indirect intense pulsed light irradiation on meibomian gland dysfunction: A randomized controlled study. Int J Ophthalmol, 2024; 17(11):2014–2022.
